Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
102M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
19M
-
Shares change
-
+1.41M
-
Total reported value, excl. options
-
$450M
-
Value change
-
+$33.8M
-
Number of buys
-
30
-
Number of sells
-
-14
-
Price
-
$23.73
Significant Holders of Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) as of Q3 2021
51 filings reported holding DAWN - Day One Biopharmaceuticals, Inc. - COMMON STOCK as of Q3 2021.
Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19M shares
of 102M outstanding shares and own 18.67% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.97M shares), FMR LLC (2.16M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.71M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.51M shares), VIKING GLOBAL INVESTORS LP (1.21M shares), BOXER CAPITAL, LLC (1.19M shares), JANUS HENDERSON GROUP PLC (1.02M shares), VANGUARD GROUP INC (820K shares), BVF INC/IL (810K shares), and FRANKLIN RESOURCES INC (591K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.